Advent Partners HLS III Limited Partnership

All filings by Advent Partners HLS III Limited Partnership on record concern Aegerion Pharmaceuticals, Inc. Between 27 October 2010 and 9 March 2012, the trades on record add up to 13 filings.

Both buying and selling appear: 1 purchase worth €20k, against 9 sales worth €42k. On balance, insiders were net sellers of €22k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2012: no purchases and 4 sales on the market.

Most recently, on 14 March 2012, the filings show an open-market sale worth €13k in Aegerion Pharmaceuticals, Inc. The last insider purchase was made public on 27 October 2010, 5,857 days ago. Most trades are made public on the day they happen. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.